School-aged Schistosoma mansoni infection levels after long-term programmatic control show failure to meet control programme targets and evidence of a persistent hotspot: evaluation of the FibroScHot trial baseline data
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0012708 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Fred Besigye und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vector Control Division, Ministry of Health, Kampala, Uganda. Hauptthemen laut MEDLINE: Schistosomiasis mansoni, Praziquantel, Schistosoma mansoni, Anthelmintics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FibroScHot, European Union, European and Developing Countries Clinical Trials Partnership.
Abstract (Originalsprache)
Background Treatment guidelines for schistosomiasis recommend increasing frequency of preventative chemotherapy (PC) administration of praziquantel to twice per annum in persistent hotspots of transmission, in combination with integrated control strategies. FibroScHot was an individual randomised superiority trial designed to examine twice per annum and four times per annum treatment frequency. It was conducted in two primary schools, Buhirigi and Kaiso, in Hoima District Uganda – a designated Schistosoma mansoni high transmission area in which PC is targeted at children and adults. The baseline parasitology data was assessed against international control programme thresholds of success and the criteria for persistent hotspots. Further, the study also assessed the potential for integrated control strategies within the surrounding communities. Methodology/principal findings The prevalence of infection, heavy infection and the infection intensity were derived for 700 participants from Kato-Katz examination of one stool sample. Neither school met the threshold of morbidity control (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vector Control Division, Ministry of Health, Kampala, Uganda.
- Department of Zoology, Entomology and Fisheries Sciences, College of Natural Sciences, Makerere University, Kampala, Uganda.
- Section for Parasitology and Aquatic Pathobiology, University of Copenhagen, Denmark.
- School of Public Health, College of Health Sciences, Makerere University, New Mulago Hill, Mulago, Kampala, Uganda.
- Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
ORCID-Profile: Shona Wilson
Förderung
- FibroScHot
- European Union
- European and Developing Countries Clinical Trials Partnership
Zitieren
APA
Besigye, F., Rowel, C., Adriko, M., Muyodi, F. J., Kisakye, J. J., Nalwanga, R., Vennervald, B. J., Nuwaha, F., Tukahebwa, E. M., & Wilson, S. (2025). School-aged Schistosoma mansoni infection levels after long-term programmatic control show failure to meet control programme targets and evidence of a persistent hotspot: evaluation of the FibroScHot trial baseline data. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012708
Vancouver
Besigye F, Rowel C, Adriko M, Muyodi FJ, Kisakye JJ, Nalwanga R, et al. School-aged Schistosoma mansoni infection levels after long-term programmatic control show failure to meet control programme targets and evidence of a persistent hotspot: evaluation of the FibroScHot trial baseline data. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012708
BibTeX
@article{Besigye2025,
author = {Besigye, Fred and Rowel, Candia and Adriko, Moses and Muyodi, Fredrick J and Kisakye, John Joseph and Nalwanga, Rosemary and Vennervald, Birgitte J and Nuwaha, Fred and Tukahebwa, Edridah M and Wilson, Shona},
title = {School-aged Schistosoma mansoni infection levels after long-term programmatic control show failure to meet control programme targets and evidence of a persistent hotspot: evaluation of the FibroScHot trial baseline data},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0012708}
}
EUVIMED